XML 15 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Investment in Joint Ventures (Details Textual) (USD $)
Share data in Millions, except Per Share data, unless otherwise specified
1 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 6 Months Ended
May 31, 2014
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Products
Jun. 30, 2013
Dec. 31, 2013
Mar. 31, 2013
Jun. 30, 2014
Medical Joint Venture
Dec. 31, 2013
Medical Joint Venture
Jun. 30, 2013
Medical Joint Venture
Jun. 30, 2014
Medical Joint Venture
Instruments
Jun. 30, 2013
Medical Joint Venture
Mar. 31, 2011
Medical Joint Venture
Jun. 30, 2014
Education Joint Venture
Jun. 30, 2013
Education Joint Venture
Jun. 30, 2014
Education Joint Venture
Mar. 31, 2013
Education Joint Venture
Jun. 30, 2014
MilestoneChinaMember
Jun. 30, 2014
Parent Company
Investment in Medical Joint Venture (Textual) [Abstract]                                      
Joint venture owned by the entity   50.00%   50.00%                 50.00%       50.00% 40.00%  
Contribution of Milestone in joint venture                     $ 1,500,000               $ 245,000
Capital contribution               1,500,000     1,500,000                
Instrument inception period                     30 months                
Contingency associated with the return of capital to Beijing 3H               0     0                
Number of development of products for medical joint venture       2                              
Number of development of instruments                     2                
Sale of stock, number of shares                 2                    
Sale of stock, price per share                 $ 1.50                    
Sale of stock, value                 3,000,000                    
Net proceeds received in joint venture 10,000,000               2,363,000                    
Percentage of ownership before transaction                 50.00%                    
Percentage of ownership after transaction                 45.50%                    
Gain on dilution effect                 1,363,650                    
Loss on joint venture   (213,193) (47,093) (343,716) (47,093)                            
Legal fees related to the FDA (510k) certifications   92,300 92,300 131,453 131,453                            
Investment in Milestone Medical Inc   760,750   760,750   924,115                          
Total expenses incurred on joint venture               469,031     756,185                
Reimbursable expense included in account receivable, net               55,424     55,424                
Other charges   216,964 77,104 351,377 94,119     107,877   12,505 132,431 12,505              
Loan from parent company CEO             50,000                        
Loss on joint venture                             (8,812) (15,643)      
Percentage of loss on joint venture                           50.00%   50.00%      
Investment in Milestone Education LLC   $ 34,261   $ 34,261   $ 42,082                       $ 1,000,000  
Distributor price per instrument                                   $ 1,295